Cargando…

Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients

Detalles Bibliográficos
Autores principales:	Gavriilaki, Eleni, Papadopoulou, Anastasia, Touloumenidou, Tasoula, Stavridou, Fani, Koravou, Evaggelia-Evdoxia, Giannaki, Maria, Papalexandri, Apostolia, Karavalakis, Georgios, Batsis, Ioannis, Kourelis, Andreas, Chatzopoulou, Fani, Chatzidimitriou, Dimitrios, Sotiropoulos, Damianos, Yannaki, Evangelia, Sakellari, Ioanna, Anagnostopoulos, Achilles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022618/ https://www.ncbi.nlm.nih.gov/pubmed/35449455 http://dx.doi.org/10.1038/s41409-022-01675-w

Ejemplares similares

Humoral and T Cell Immune Responses to Sars-Cov-2 Vaccination in Hematopoietic Cell Transplant Recipients
por: Gavriilaki, Eleni, et al.
Publicado: (2021)

Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek Center
por: Varelas, Christos, et al.
Publicado: (2022)

Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation
por: Gavriilaki, Eleni, et al.
Publicado: (2020)

Targeted genotyping of COVID-19 patients reveals a signature of complement C3 and factor B coding SNPs associated with severe infection
por: Tsiftsoglou, Stefanos A., et al.
Publicado: (2023)

Robust SARS-COV-2-specific T-cell immune memory persists long-term in immunocompetent individuals post BNT162b2 double shot
por: Papadopoulou, Anastasia, et al.
Publicado: (2022)

Thrombotic Microangiopathy Variants Are Independently Associated with Critical Disease in COVID-19 Patients
por: Gavriilaki, Eleni, et al.
Publicado: (2020)

Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes
por: Papalexandri, Apostolia, et al.
Publicado: (2023)

Genetic justification of severe COVID-19 using a rigorous algorithm
por: Gavriilaki, Eleni, et al.
Publicado: (2021)

Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia
por: Gavriilaki, Eleni, et al.
Publicado: (2018)

PB2226: THE ROLE OF COMPLEMENT IN THE IMMUNE RESPONSE OF SICKLE CELL DISEASE PATIENTS AFER COVID-19 VACCINATION
por: Varelas, C., et al.
Publicado: (2022)

Identification of Complement-Related Missense Variants in Pediatric Patients with Acute and Post COVID-19 Syndromes
por: Gavriilaki, Eleni, et al.
Publicado: (2021)

Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection
por: Gavriilaki, Eleni, et al.
Publicado: (2022)

P1311: LONG-TERM SAFETY AND EFFICACY OF EXTRACORPOREAL PHOTOPHERESIS AS EARLY SECOND-LINE TREATMENT FOR PATIENTS WITH STEROID-DEPENDENT OR REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE.
por: Gavriilaki, Eleni, et al.
Publicado: (2023)

Genetic prediction of ICU hospitalization and mortality in COVID‐19 patients using artificial neural networks
por: Asteris, Panagiotis G., et al.
Publicado: (2022)

P1395: PENTAVALENT-SPECIFIC T-CELLS POST HAPLO-IDENTICAL TRANSPLANTATION FOR THE TREATMENT OF OPPORTUNISTIC INFECTIONS
por: Bousiou, Zoi, et al.
Publicado: (2023)

Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity
por: Papadopoulou, Anastasia, et al.
Publicado: (2021)

Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls
por: Gavriilaki, Eleni, et al.
Publicado: (2022)

Outcomes of Patients with Hematologic Malignancies and COVID-19: Perspective of a Large Hematology Center in Greece
por: Spyridis, Nikolaos, et al.
Publicado: (2021)

PB1894: NPM1 MUTATED ACUTE MYELOID LEUKEMIA: THE CO-MUTATION PATTERNS MAY BE ASSOCIATED WITH PROGNOSIS
por: Varelas, Christos, et al.
Publicado: (2023)

PB2183: RELAPSE PREDICTS POOR OUTCOMES IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
por: Gavriilaki, E., et al.
Publicado: (2022)

Allogeneic Hematopoietic Cell Transplantation in Patients With Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Clones: Time for a Change
por: Gavriilaki, Eleni, et al.
Publicado: (2020)

A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of Immunity
por: Gavriilaki, Eleni, et al.
Publicado: (2020)

Thrombocytopenia in COVID-19: pathophysiology matters
por: Gavriilaki, Eleni, et al.
Publicado: (2020)

Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation
por: Gavriilaki, Eleni, et al.
Publicado: (2021)

Blast Crisis of CML After TKI Discontinuation in a Patient With Previous Stable Deep Molecular Response: Is It Safe to Stop?
por: Papalexandri, Apostolia, et al.
Publicado: (2018)

Risk Factors, Prevalence, and Outcomes of Invasive Fungal Disease Post Hematopoietic Cell Transplantation and Cellular Therapies: A Retrospective Monocenter Real-Life Analysis
por: Gavriilaki, Eleni, et al.
Publicado: (2023)

Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel Agents
por: Gavriilaki, Maria, et al.
Publicado: (2019)

Reinforcing the Immunocompromised Host Defense against Fungi: Progress beyond the Current State of the Art
por: Karavalakis, Georgios, et al.
Publicado: (2021)

The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD)
por: Demosthenous, Christos, et al.
Publicado: (2021)

Vaccinated and Convalescent Donor–Derived Severe Acute Respiratory Syndrome Coronavirus 2–Specific T Cells as Adoptive Immunotherapy for High-Risk Coronavirus Disease 2019 Patients
por: Papayanni, Penelope-Georgia, et al.
Publicado: (2021)

Neurologic complications after allogeneic transplantation: a meta‐analysis
por: Gavriilaki, Maria, et al.
Publicado: (2019)

P1698: INCREASED COMPLEMENT ACTIVATION AND DECREASED ADAMTS13 ACTIVITY IN PATIENTS WITH PRE-ECLAMPSIA COMPARED TO HEALTHY PREGNANCIES
por: Venou, T. M., et al.
Publicado: (2022)

Pathogen-specific T Cells: Targeting Old Enemies and New Invaders in Transplantation and Beyond
por: Papadopoulou, Anastasia, et al.
Publicado: (2023)

Prevalence and correlates of persistent intracellular HIV transcription in individuals on efavirenz versus atazanavir-based regimens: A prospective cohort study
por: Pilalas, Dimitrios, et al.
Publicado: (2018)

Identification of complement-related host genetic risk factors associated with influenza A(H1N1)pdm09 outcome: challenges ahead
por: Chatzopoulou, Fani, et al.
Publicado: (2018)

PB2261: DECREASE IN NEUTROPHIL-LYMPHOCYTE RATIO IMPACTS OVERALL SURVIVAL OF ADULT PATIENTS WITH HODGKIN LYMPHOMA AFTER ANTI-PD1 TREATMENT
por: Varelas, Christos, et al.
Publicado: (2023)

Molecular Advances in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease
por: Mavrikou, Ioulia, et al.
Publicado: (2023)

Molecular and Clinical Characteristics of Different Toxicity Rates in Anti-CD19 Chimeric Antigen Receptor T Cells: Real-World Experience
por: Gavriilaki, E., et al.
Publicado: (2023)

Assessment of Endothelial Injury and Pro-Coagulant Activity Using Circulating Microvesicles in Survivors of Allogeneic Hematopoietic Cell Transplantation
por: Gavriilaki, Eleni, et al.
Publicado: (2020)

Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter data
por: Gavriilaki, Eleni, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_necr3idekiscvhj2q1vtnn6amt